Adaptive Biotechnologies
ADPT
$10.39
Share price
-2.07%
Change (1 day)
134.01%
Change (1 year)
Categories
Operating Margin for Adaptive Biotechnologies (ADPT)
Operating Margin as of July 2025 (TTM): -68.80%
According to Adaptive Biotechnologies 's latest financial reports and stock price the company's current Operating Margin is -68.80%. At the end of 2024 the company had an Operating Margin of -89.18%.
Operating Margin history for Adaptive Biotechnologies from 2018 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -89.18% | -32.6% |
| 2023 | -132.32% | 22.37% |
| 2022 | -108.13% | -19.49% |
| 2021 | -134.31% | -9.64% |
| 2020 | -148.63% | 84.3% |
| 2019 | -80.65% | -3.35% |
| 2018 | -83.44% | -25.1% |
| 2017 | -111.40% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | 12.07% | -117.54% | 🇺🇸 USA |
 Premier PINC | 6.45% | -109.38% | 🇺🇸 USA |
 Community Health Systems
CYH | -2.23% | -96.76% | 🇺🇸 USA |
 Select Medical Holdings SEM | 4.71% | -106.85% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.